Sitemap
August 06, 2016 Articles
Filter by Available Specialty
- Continuous lenalidomide, dexamethasone improves PFS, OS for multiple myeloma across age groups
- DJO Global announces second-quarter financial results for 2016
- Many Canadians unaware of increased risk for hepatitis C
- Metabolic syndrome provides minimal prognostic value for serious adverse events after ACS
- Orexigen acquires US rights to Contrave
- Study of genomics of antiplatelet therapy continues
- VIDEO: Trastuzumab biosimilar demonstrates safety, efficacy in advanced breast cancer
- VIDEO: Treatment, management options for patients with intermediate uveitis